GI
XBI icon

GAMMA Investing’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

GAMMA Investing’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.2K Buy
589
+530
+898% +$71.6K ﹤0.01% 1858
2026
Q1 		$7.54K Buy
59
+51
+638% +$6.37K ﹤0.01% 3205
2025
Q4 		$975 Hold
8
– – ﹤0.01% 3797
2025
Q3 		$802 Buy
+8
New +$721 ﹤0.01% 3647
2025
Q2 		– Sell
-260
Closed -$21.1K – 3898
2025
Q1 		$21.1K Sell
260
-72
-22% -$6.43K ﹤0.01% 2350
2024
Q4 		$29.9K Sell
332
-759
-70% -$73.5K ﹤0.01% 2040
2024
Q3 		$108K Buy
1,091
+1,076
+7,173% +$106K 0.01% 948
2024
Q2 		$1.39K Hold
15
– – ﹤0.01% 2983
2024
Q1 		$1.42K Sell
15
-10
-40% -$928 ﹤0.01% 2856
2023
Q4 		$2.19K Buy
+25
New +$1.86K ﹤0.01% 2555

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

GAMMA Investing's XBI Position: Q2 2026 in Review

GAMMA Investing increased its State Street SPDR S&P Biotech ETF (XBI) stake by 898% in Q2 2026, buying an estimated $71.6K and bringing the position to 589 shares worth $93.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1858.

GAMMA Investing first reported a position in XBI in Q4 2023 and has held it in 10 quarters since. The position peaked at $108K in Q3 2024. 225 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • GAMMA Investing held 589 shares of State Street SPDR S&P Biotech ETF worth $93.2K as of Q2 2026.
  • GAMMA Investing bought 530 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $71.6K.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1858 holding.
  • GAMMA Investing first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 10 quarters since.
  • GAMMA Investing's State Street SPDR S&P Biotech ETF position peaked at $108K in Q3 2024.
  • 225 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.